Gabriella Gaudioso

Medicine & Life Sciences

1. MicroRNAs 100%
2. Tensins 84%
3. Enteropathy-Associated T-Cell Lymphoma 78%
4. Celiac Disease 71%
5. Phosphoric Monoester Hydrolases 66%
6. Non-Small Cell Lung Carcinoma 47%
7. Neoplasms 47%
8. Precision Medicine 45%
9. T-Cell Lymphoma 42%
10. Breast Neoplasms 41%
11. DNA Mismatch Repair 38%
12. Biomarkers 38%
13. Lung Transplantation 37%
14. Mitochondrial Dynamics 36%
15. Voltage-Dependent Anion Channel 1 36%
16. Interleukin-15 35%
17. Adenosine Triphosphatases 32%
18. Gliadin 25%
19. Peripheral T-Cell Lymphoma 25%
20. Janus Kinases 24%
21. Bronchoalveolar Lavage 23%
22. Benchmarking 23%
23. Ligands 23%
24. Glioma 22%
25. Essential Thrombocythemia 21%
26. Fulvestrant 21%
27. Anaplastic Lymphoma Kinase 21%
28. Cellular Reprogramming 20%
29. Glioblastoma 20%
30. DNA Damage 19%
31. Gene Dosage 19%
32. Gene Amplification 19%
33. Pre-Analytical Phase 18%
34. Peptidomimetics 17%
35. Giant Cells 17%
36. Permeability 17%
37. Pandemics 17%
38. Osteoclasts 16%
39. Transgenic Mice 16%
40. Stromal Cells 16%
41. Cell Death 15%
42. pembrolizumab 15%
43. Psychological Inhibition 15%
44. Methylation 14%
45. Genes 13%
46. Growth 13%
47. Immunosuppressive Agents 13%
48. Mental Health 12%
49. Signal Transduction 12%
50. Transcription Factors 12%